Abstract:Objectives and scope Primary mitochondrial diseases (PMDs) are rare genetic disorders resulting from mutations in genes crucial for effective oxidative phosphorylation (OXPHOS) that can affect mitochondrial function. In this review, we examine the bioenergetic alterations and oxidative stress observed in cellular models of primary mitochondrial diseases (PMDs), shedding light on the intricate complexity between mitochondrial dysfunction and cellular pathology. We explore the diverse cellular models utilized to study PMDs, including patient‐derived fibroblasts, induced pluripotent stem cells (iPSCs) and cybrids. Moreover, we also emphasize the connection between oxidative stress and neuroinflammation. Insights The central nervous system (CNS) is particularly vulnerable to mitochondrial dysfunction due to its dependence on aerobic metabolism and the correct functioning of OXPHOS. Similar to other neurodegenerative diseases affecting the CNS, individuals with PMDs exhibit several neuroinflammatory hallmarks alongside neurodegeneration, a pattern also extensively observed in mouse models of mitochondrial diseases. Based on histopathological analysis of postmortem human brain tissue and findings in mouse models of PMDs, we posit that neuroinflammation is not merely a consequence of neurodegeneration but a potential pathogenic mechanism for disease progression that deserves further investigation. This recognition may pave the way for novel therapeutic strategies for this group of devastating diseases that currently lack effective treatments. Summary In summary, this review provides a comprehensive overview of bioenergetic alterations and redox imbalance in cellular models of PMDs while underscoring the significance of neuroinflammation as a potential driver in disease progression.

Mitochondrial membrane synthesis, remodelling and cellular trafficking

Cardiolipin Remodeling: a Regulatory Hub for Modulating Cardiolipin Metabolism and Function

Therapeutic and tampering approaches for mitochondrial associated diseases

Mitochondrial membrane lipid remodeling in pathophysiology: a new target for diet and therapeutic interventions

Post-translational modifications in mitochondria: protein signaling in the powerhouse

Disorders of phospholipid metabolism: an emerging class of mitochondrial disease due to defects in nuclear genes

Molecular mechanisms of mitochondrial dynamics

Mitochondrial Dysfunction: A Cellular and Molecular Hub in Pathology of Metabolic Diseases and Infection

Mitochondria and Lipid Droplets: Focus on the Molecular Structure of Contact Sites in the Pathogenesis of Metabolic Syndrome

Mitochondrial cardiolipin/phospholipid trafficking: The role of membrane contact site complexes and lipid transfer proteins

Disruption of Mitochondrial Quality Control in Inherited Metabolic Disorders

An Insight into the Approach Taken to Appurtenances Disorders Linked to Mitochondria

Molecular and Supramolecular Structure of the Mitochondrial Oxidative Phosphorylation System: Implications for Pathology

Skeletal Phenotypes Due to Abnormalities in Mitochondrial Protein Homeostasis and Import

Mitochondrial membrane lipids in the regulation of bioenergetic flux

Nuclear and Cytoplasmatic Players in Mitochondria-Related CNS Disorders: Chromatin Modifications and Subcellular Trafficking

Molecular pathways in mitochondrial disorders due to a defective mitochondrial protein synthesis

Secondary mitochondrial dysfunction across the spectrum of hereditary and acquired muscle disorders

Mitochondria in health, disease, and aging

The role of mitochondrial dynamics in disease

Primary mitochondrial diseases: The intertwined pathophysiology of bioenergetic dysregulation, oxidative stress and neuroinflammation